Annual Drug Patent Expirations for ELLA
Ella is a drug marketed by Lab Hra Pharma and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ELLA.
This drug has fifty-five patent family members in twenty-eight countries.
The generic ingredient in ELLA is ulipristal acetate. One supplier is listed for this compound. Additional details are available on the ulipristal acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
